9
report
Strengthening the Biomedical Innovation Ecosystem: A Scorecard for System Assessment
As patients, we often evaluate our interactions within the "system" of biomedical innovation with a
simple question: "Did it work for me?" This evaluation considers many issues, including whether the best treatments are accessible and available, how the
+ Read More
report
Cell and Gene Therapies: Looking Ahead to 2022
Cell and gene therapies are a new category of medicines transforming how we treat and potentially c
ure disease. Both cell and gene therapies seek to modify genetic material to fight disease.
+ Read More
report
A Call to Action for Health Equity: Solutions from the Front Lines for Local and National Efforts
FasterCures is advancing system change within biomedical research to focus on and value diversity a
nd representation within clinical trials and the workforce.
+ Read More
video
Technology Enabling Decentralized Trials, Novel Endpoints, Real World Data
New technologies and approaches to collection and use of patient data have the potential to revolu
tionize clinical research. How can patient organizations support this movement? What are potential pitfalls to watch out for?
+ Read More
video
Master Protocols, Adaptive Designs, and Bayesian Statistics – Oh My
Master Protocols, Adaptive Designs, and Bayesian Statistics: These innovative trial approaches are
sometimes described as being “patient-centric.” Are they? What are the challenges and opportunities for patient groups to support them?
+ Read More
video
Opportunities for Patient Group Engagement in Clinical Trials
What is the range of opportunities for patient foundations to support more rapid and effective cli
nical research, through preference studies and other patient insights, trial design and networks, recruitment and retention?
+ Read More
video
The Drive for More Diverse and Representative Clinical Trials
How can foundations help to drive diverse and representative clinical trials in the face of long s
tanding racial and ethnic disparities in healthcare and research?
+ Read More
article
Letter of Support: Reauthorization of Food and Drug Administration (FDA) User Fee Programs
Submitted electronically
article
Antibiotic Resistance and Chronic Disease: Understanding the Challenges and Possible Solutions Webinar Summary
Antimicrobial resistance (AMR) poses a threat to everyone. However, some patients with chronic illne
sses are significantly more likely to become infected with antibiotic-resistant bacteria than those without chronic disease.
+ Read More